Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis

NCT05363449 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinea Cruris
Tinea Pedis

Interventions

DRUG: UHE-103 Cream
DRUG: Naftin (naftifine hydrochloride) Cream

Sponsor

Therapeutics, Inc.